• Products and services commercialized in over 35 countries via global network of resellers and distributors
• Intellectual property portfolio includes more than 80 patents and patents pending
• The first wearable technology company, with a strong pipeline of award-winning products targeting B2B, B2C and military sectors
• Company leverages IoT and wearable technology experience to develop small and discrete low-power GPS, cellular, BLE and RF tracking solutions
• Flagship product GPS SmartSole® developed specifically to track people with cognitive disorders who are at risk of wondering – an expanding market likely to reach 277 million people by 2050

GTX Corp (OTC: GTXO) designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://ibn.fm/69Lyd), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

• Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
• Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
• Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
• T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
• GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

For more information, visit the company’s website at www.GTXCorp.com

• Netevia platform now includes a smart vendor payments solution
• New feature marks Netevia’s entry into $7.7 trillion B2B sales market
• New solution streamlines B2B payments and cuts costs associated with sending payments

Global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) recently announced that it has extended its next-generation Netevia platform to now include a smart solution that enables secure vendor payment transactions.

With its intuitive, user-centric web and mobile platform interface, this vendor payments solution effectively streamlines B2B payments by enhancing payment processes and also cuts the costs associated with sending payments.

As B2B business continues to dwarf B2C business—with global B2B sales estimated at $7.7 trillion, according to Statista, while B2C sales trail far behind at $2.3 trillion—Netevia’s cutting-edge solution is just what this booming market needs to resolve key issues. Standout features of Netevia include:

• The ability to safely and electronically deliver payments utilizing a secure, single-use dynamic credit card number; only the designated single vendor can process these payments, and only for a specific amount; additional controls have been included to enhance security and flexibility
• Works seamlessly with existing accounting systems, requiring no complicated setup or integration
• Customer support is available 24/7 via phone, email and live chat

Netevia gives business owners all the building blocks they need to integrate payment acceptance into their e-commerce solutions, granting them immediate access to the sandbox for integration and providing them with quick merchant account approval.

Enabling vendor payments on the Netevia platform further solidifies Netevia as a premium market platform that arms SMBs with innovative, comprehensive card payments-oriented solutions to help them improve their operations. Additional exciting features on the horizon for Netevia include:

• Free processing in exchange for data;
• A gift card solution to drive repeat business and increase sales;
• Cryptocurrency payment processing solutions for multichannel transactions; and
• Integration with smart terminals for card present sales.

For more information, visit the company’s website at www.NetElement.com

• Significant changes within politics paint a promising picture for the cannabinoid industry
• MCOA is involved in the cultivation, manufacture and distribution of hemp-derived products
• MCOA recently announced the launch of its reformulated, patent pending product, hempSMART™ Brain

President Trump recently made the statement that he is likely to back the States Act introduced by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA), which removes federal involvement into state-by-state medical and recreational cannabis legislation. This is great news for those in the U.S. cannabinoid market (http://ibn.fm/Zq54b). Also, significant changes have taken place in the political acceptance of the cultivation of hemp on American soil. In a bipartisan move, Senator Chuck Schumer (D-NY) announced last month he will be signing Senator Mitch McConnell’s (R-KY) Industrial Hemp Farming Act of 2018. The bill seeks to remove industrial hemp from the same definition of marijuana under the Controlled Substances Act. Schumer referred to the current federal law as a crock, stating, “It makes no sense that the DEA is the primary regulator, and that they stop farmers and investors from growing hemp. Why are we buying hemp from other countries, when we have hundreds of acres that could be grown right here in our backyard?” (http://ibn.fm/YI66f).

Marijuana Company of America, Inc. (OTC: MCOA) operates as an umbrella company supporting a variety of portfolio businesses that participate within the legal cannabis and hemp industry by providing turnkey products and services. First and foremost an industrial hemp company, the majority of MCOA’s offerings relate to the cultivation and distribution of hemp-derived products.

MCOA announced on June 5, 2018, its hempSMART™ brand relaunched its flagship patent pending product, hempSMART™ Brain. In a news release, Donald Steinberg, CEO of MCOA, stated, “After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”

The improved formulation includes 300mg per bottle of full spectrum, non-psychoactive, water soluble CBD (10mg per serving), along with a botanical blend of all-natural plant-based ingredients. To learn more about the hempSMART™ Brain product, read the full press release (http://ibn.fm/xZENn). The brand offers a line of CBD products and the opportunity to distribute the products as part of an affiliate network marketing model.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

Important Information

Marijuana Company of America, Inc. (“Company”) complies with Section 17(b) of the 1933 Securities and Exchange Act. The Company retained NetworkNewsWire to publish information about the Company. To comply with Section 17(b) of the Securities Act of 1933, the Company discloses that it retained and paid Network News Wire with a cash payment of $5,000 per month to publish news, updates, articles and content about the Company.

• Number and value of cryptocurrencies continue to rise
• Cryptocurrency ATM market set for CAGR of 46 percent until 2025
• NetoBit ATM allows purchase and sale of bitcoin

Accurate estimates of the value of cryptocurrencies in circulation appear to be eluding analysts. Writing in December 2017, one suggested ‘the total value of all cryptocurrency in circulation is now almost $100bn’ (http://ibn.fm/U7jv5). Around the same time, the Washington Post estimated the value of the 16.7 million bitcoin then in circulation at $189 billion (http://ibn.fm/lZMqx). Counting cryptocurrencies is tough, particularly as analysts take aim at a moving target. Not only the value but also the number of currencies keeps changing. In December 2017, ‘there were 1,324 cryptocurrencies listed on CoinMarketCap.com’. By June 13, 2018, with the addition of Aston, Press One and Candy, that number had increased by 23 percent to 1,628.

Regardless of the final figure, the consensus is of a market that is large and growing larger, factors that make it increasingly important to facilitate exchange between crypto and fiat currencies. Recognizing how crucial that link is, Virtual Crypto Technologies Inc. (OTCQB: VRCP), an Israeli-based company dedicated to the mission of making cryptocurrencies accessible to the public, is now offering a bitcoin ATM. By allowing bitcoin to be exchanged for fiat currencies and vice versa, Virtual Crypto’s NetoBit ATM is opening a gateway from the crypto to the fiat universe, an ideal environment for modern tech savvy consumers.

With a probable value of around $300 billion, alt-currency is no longer confined to the sidelines. It is now about one-fifth as large as traditional U.S. currency in circulation, which, as of March 21, 2018, was approximately $1.63 trillion (http://ibn.fm/E0IE2). The growth of cryptocurrencies is fueling a rise of the machines. In December 2013, there were just four ATMs worldwide that could handle bitcoin. Now, there are over 3,000 bitcoin ATMs in operation around the world, according to Coin ATM Radar (http://ibn.fm/7h5yF). Further growth is envisaged. The size of the cryptocurrency ATM market in 2017 was around $14 billion, and it’s expected to grow at a compound average growth rate (CAGR) of 46 percent until 2025, according to a study by Coherent Market Insights.

Generally, these crypto-ATMs grant access to bitcoin by allowing its purchase. However, Virtual Crypto’s NetoBit ATM is different. The platform is bi-directional, allowing the purchase of bitcoin with fiat currency and the sale of bitcoin for fiat currency (http://ibn.fm/pDKGm). As such, the NetoBit ATM is the world’s first and only ATM that allows real-time conversion, purchase and sale of Bitcoin. Its hardware and software has embedded currency exchange transaction validation (CETV), which provides rapid confirmation of transactions, allowing customers to withdraw cash and transfer funds to and from their crypto accounts in seconds. Users also receive attractive exchange rates, since the system has links to several cryptocurrency exchanges. The ATM, which already supports most common currencies, is now available for purchase globally.

Virtual Crypto already has a solution on the market for retailers, which is based on the same technology. In April, it launched NetoBit Pay, a retail point-of-sale (POS) device that enables businesses worldwide to securely receive payments in bitcoin in real time, while at the same time enjoying protection against exchange rate volatility and guaranteeing transactions up to a value of $3,000. The company is rapidly executing its plan to bring cryptocurrencies to the masses (http://ibn.fm/X9ntN). As part of this strategy, VRCP aims to target the online video game and ecommerce market, which employs cryptocurrencies extensively.

For more information, visit the company’s website at www.Virtual-Crypto.com

• CEO John ‘JT’ Thatch applauds Elepreneurs team for its execution of go-to-market concept, which led to $2.4 million in March sales, doubling previous month
• SHRV’s unique Blue Ocean Strategy cited by Robert Oblon, chairman of SHRV, for its contribution to direct selling success
• Elevacity, company’s new health-and-wellness division, lauded for helping drive SHRV’s sales growth

Sharing Services, Inc. (OTC: SHRV) has reported that execution by its marketing team of Elepreneurs of direct-to-market selling and the application of its unique Blue Ocean strategy, plus the debut of its Elevacity health-and-wellness division, helped generate significant sales growth. Most spectacular was the company’s earlier $2.4 million gross sales for March, doubling the previous month’s total (http://ibn.fm/qjvPx).

The title ‘elepreneur’ is a combination of the words elevate and entrepreneur. This is a team of home-based independent sales representatives who are trained to direct sell end user consumers. Elevacity’s wellness products include Vitamin Patches that are designed to generate energy, anti-aging Elier Mud, and the Timeless line of skincare products for men and women.

SHRV is a Plano, Texas-based diversified holding company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services such as energy, technology and insurance. It completed a joint venture agreement with Hong Kong-based Health Wealth & Happiness Ltd. (HWH) to sell its products throughout Asia and expand its Elepreneur program (http://ibn.fm/Oeace).

Go-to-market is a selling technique focused on the end user when delivering a product or service. It involves connecting closely with potential clients. “We have an incredible team of Elepreneurs in that division (Elevacity) and they are executing our go-to-market strategy flawlessly. In addition our customers seem very pleased with the products as we continue to grow in the marketplace,” John ‘JT’ Thatch, CEO of SHRV, stated in a news release (http://ibn.fm/0FRYK).

Robert Oblon, chairman of the company, added that the application of SHRV’s unique Blue Ocean Strategy concept, supported by its best-in-class products and services, is succeeding (http://ibn.fm/N342U). That strategy is defined as selling in an uncontested marketplace.

For more information, visit the company’s website at www.SharingServicesInc.com

The U.S. now has 22 states that have legalized medical marijuana, 16 that have approved the usage of CBD and THC products and eight that have legalized recreational cannabis use. Marijuana use in Canada is generally legalized, and there is a total of 105 authorized licensed producers (LPs), with eight provinces allowing homegrown cannabis. In a recent report, JGR Capital, a New York-based equity research firm, highlighted the largest single U.S. cannabis company listed on the Canadian exchange, plus four cannabis-related companies that have raised capital.

Los Angeles-based cannabis producer MM Enterprises, now renamed MedMen Enterprises (CSE: MMEN) following a reverse merger, is the largest U.S. cannabis company listed on the Canadian Securities Exchange. The company’s short position in cannabis-related stocks reached a record high of over 200 million shares. Through a private placement, the company has raised C$143 million, placing the value of the organization at C$2.14 billion ($1.65 billion).

Emerald Health Therapeutics (OTCQX: EMHTF) recently announced that it closed the sale of four million share units for gross proceeds of C$16.80 million (~$13.04 million). Net proceeds will go toward further development of projects in Las Vegas, Washington State and California.

Speakeasy Cannabis Club (OTC: SPBBF) recently closed the first tranche of its non-brokered private placement of 4.9 million units, bringing in gross proceeds of C$4.90 million (~$3.80 million). The proceeds of this private placement will go toward general working capital.

Village Farms Internationals (OTCQX: VFFIF) completed a private placement of company shares for gross proceeds of approximately C$10 million (~$7.76 million). Net proceeds from this offering will be used to contribute capital, if required, to Pure Sunfarms, as well as general working capital purposes. Pure Sunfarms is a 50 percent-owned JV with Emerald Health Therapeutics, and it is currently increasing commercial production at its 1.1 million sq. ft. greenhouse.

For more information, view the complete JGR Capital report at http://ibn.fm/CT5zg

• Chris Bunka, CEO of LXRP, in an interview with CFN Media Group, stated that his company’s cash flow is strengthening from licensing and R&D, with technology applicable to other sectors
• Bunka noted that LXRP’s 71 million share count is kept purposely low relative to others in the category, with its valuation growing by “close to 2,000 percent” over the past several years
• LXRP’s goal is to slow disease and make cannabis acceptable to the general population

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in value and cash flow, purposely keeping its cash burn rate down and evaluating technology applications for both cannabis and other sectors (http://ibn.fm/6gBzv).

Bunka explained that LXRP is respecting its shareholders in terms of lowered spending and increasing its valuation, purposely maintaining its outstanding share count at relatively low levels. He said that LXRP is building its cash flow through licensing and R&D, as its technology can be used in other sectors besides cannabis. The company is focused on cannabinoid delivery R&D with its DehydraTECH™ technology, which enhances the performance of beneficial compounds in ingestible products, but it can be used across multiple categories, such as nicotine absorption. The result of all this, according to Bunka, is investors that are respected and a valuation of the company that has grown “by close to 2,000 percent’ in recent years.

Based in British Columbia, Canada, LXRP out-licenses its disruptive delivery technology that promotes healthier ingestion methods, resulting in lower dosing and higher effectiveness. LXRP holds a patent for oral delivery of all cannabinoids.

The company’s patented DehydraTECH™ is key to LXRP’s valuation. “We believe that infused foods should taste more like food and less like marijuana,” Bunka noted in the interview. “Our consumers find their coffee tastes a bit more like coffee and less like cannabis, and additionally notice that the cannabinoids take effect faster, and they feel a different type of effect than the typical edible. For medical patients who medicate often, that difference means a lot.”

Bunka explained that, within the tobacco and nicotine industry, recent lab tests have shown a 50 percent improvement in nicotine absorption into the bloodstream of rats with its technology, as compared to a control group. It found even higher percentage levels – 560 percent – of nicotine absorbed in brain tissue. It was a surprising result that might lead to development of cigarette smoking-cessation products by satisfying cravings for nicotine for extended periods of time. He said that these results, if replicated in human trials, could have a profound impact on treatment of cancer and brain tumors in the pharmaceutical and biotech sectors, making Lexaria’s technology a candidate for much more than cannabis applications.

The company’s patent portfolio is growing. It already has more than 40 patent applications or awards in more than 40 countries. Late last year, LXRP received its first U.S. patent on nicotine, ibuprofen and aspirin delivery, as well as cannabinoids. Bunka explained that the company is in the “active investigation phase” in the EU, Canada, China, Japan and India for more patents. “We’re filing new patent applications all the time,” he added.

For more information, visit the company’s website at www.LexariaEnergy.com

• CIIX’s strategy is to blanket Chinese-speaking population in America with daily cryptocurrency broadcast from NYSE, podcast, online site, ATMs, mining operation and educational courses
• Bitcoin and blockchain show is on Phoenix North America Chinese Channel and will also be broadcast online at NewCoins168.com, CIIX’s website, and its YouTube channel
• CIIX has established a cryptocurrency mining operation and signed an LOI to acquire the assets of XBTeller.com for some $2.5 million; that company has nine Bitcoin ATMs in Colorado

ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a new 22-minute monthly TV program titled ‘Bitcoin Talk Show’, which it expects will reach more than 500,000 Chinese-speaking individuals through the Phoenix North America Chinese Channel. It will also be seen on the company’s YouTube and ChineseFN channels, as well as CIIX’s online site, NewCoins168.com (http://ibn.fm/mvqIx). CIIX has signed an LOI to acquire bitcoin ATM operator XB Teller.com (http://ibn.fm/TtIgi), and it has entered a licensing partnership with ‘The Bad Crypto Podcast’ to rebroadcast some of its most popular shows in Chinese (http://ibn.fm/du8m5).

All of this activity reinforces CIIX’s strategy of educating then broadcasting, by internet, cable TV and podcast, news about bitcoin and other cryptocurrencies to its targeted Chinese-speaking audience. The Bitcoin Talk Show will broadcast on the Direct TV and EchoStar satellite systems in both traditional and simplified Chinese. Through Time Warner Cable, the show is expected to reach more than 500,000 in the U.S. alone, CIIX said. That figure is a significant share of the estimated 3.3 million Chinese-speaking people in the U.S., according to the Census Bureau back in 2010 (http://ibn.fm/UUEcy).

CIIX is a diverse educational and consulting company aimed at the Chinese-speaking community located in China and the U.S. Its primary revenue streams have been from subscriptions and investor relations. Most recently, it has offered educational and sales services in cryptocurrency, particularly bitcoin. CIIX’s goal is to become the leading Chinese publicly-traded company that offers real-time information. It projects a 30 percent revenue gain in its fiscal year ended May 31, 2018 (http://ibn.fm/GxfoN).

CIIX has already established itself as a primary and diverse provider of cryptocurrency education to the Chinese-speaking population globally and, specifically, in North America. Not only does it own a daily video broadcast from the NYSE called ‘Bitcoin MultiMillionaire’; it also hosts a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters. The company has acquired ASIC machines and is mining for virtual currency in a datacenter near Seattle.

For more information, visit the company’s website at www.ChineseInvestors.com

• AnalytixInsight’s first-quarter report notes 200 percent jump in year-over-year revenues
• Market analysts foresee big data industry reaching $84 billion level by 2024
• Company’s partners include European bank Intesa Sanpaolo, multi-national media giant Thomson Reuters

Building on a year of growth that led to its designation as “one of the top 10 performing technology companies in the 2018 Venture 50” with a market cap change of 288 percent on the Canadian TSX exchange (http://ibn.fm/fdPkl), artificial intelligence data delivery company AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is off to a strong start for 2018 with a 200 percent-plus increase in revenue year-over-year, as noted in its first-quarter financial results reported on May 30 (http://ibn.fm/0JphQ). While companies worldwide strive to build success and weather market uncertainties, AnalytixInsight has found appeal with those seeking a measure of security in the form of data-driven analysis on the competition, as well as the companies’ internal systems.

AnalytixInsight’s AI-based fintech platform CapitalCube is finding licensees among leading financial news agencies, web portals and stock exchanges. Amid the modern era’s insatiable desire for actionable information that crosses national borders and continental divides, CapitalCube culls information on more than 50,000 globally listed stocks and North American ETFs (exchange-traded funds), producing 100 billion daily computations.

The information industry can be profitable. Market analysts at Statista predict that revenues generated by the big data and business analytics industry will jump 100 percent from their estimated $42 billion level this year to $84 billion in six years (http://ibn.fm/bNkk2). The trend bespeaks the transformative power of technology on a business’s bottom line.

AnalytixInsight’s report notes that it closed the quarter with revenues of $1.01 million and operating capital of $1.82 million.

Euronext, the leading pan-European exchange in the Eurozone, has embedded the company’s analytics tech within its “Market Insight” app, which is being deployed as a real-time stock trading solution. AnalytixInsight’s subsidiary, MarketWall, has also embedded the company’s analytics content within its MarketWall app, which is expect to be rolled out later this year by Italy’s largest retail bank, Intesa Sanpaolo. The bank has 12.6 million customers across Europe.

Thomson Reuters, a media company that has provided information for the world’s professional markets for over a century, completed a research distribution agreement with CapitalCube early in the quarter, through which Thomson Reuters will supply AnalytixInsight’s machine-learning platform with information and then distribute the resulting product to customers via financial desktop applications Eikon and Thomson One. The distribution of AnalytixInsight’s financial research reports will be implemented in phases, beginning late in 2018.

“We are making great progress with our existing strategic partners and we are working with more potential new partners. Both the financial and workforce management industries are quickly embracing machine-learning, and we are witnessing a shift in thinking as industry participants now look to incorporate machine-learning into their business solutions,” AnalytixInsight president and CEO Prakash Hariharan stated in summation of the quarterly report.

For more information, visit the company’s website at www.AnalytixInsight.com

• Focused on California, the largest legal cannabis market in North America
• Operates an attractive royalty model that is beneficial for operators and the company
• Established partnerships with best-in-class operating entities
• Extensive network provides access to top-tier projects and operators
• Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

For more information, visit the company’s website at www.FinCannaCapital.com

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.